SCHEMBL9949412

SCHEMBL9949412

CC1CCC(C(C)c2ccc(C=O)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.50
ALDH1A3 P47895 2/20 0.42
GRIA4 P48058 1/20 0.37
CYP2A6 P11509 3/20 0.36
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
ALDH1A1 P00352 5/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
CYP2A13 Q16696 1/20 0.33
BRD4 O60885 1/20 0.33
HSD17B10 Q99714 1/20 0.32
ALDH5A1 P51649 1/20 0.32
ABAT P80404 1/20 0.32
DRD1 P21728 2/20 0.32
ALDH3A1 P30838 1/20 0.32
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL9951283 0.85 TYR (0.37) TYRALDH1A3GRIA4BRD4
SCHEMBL9950279 0.84 TYR (0.52) TYRALDH1A3GRIA4CYP2A6SLC6A2
SCHEMBL9950187 0.82 TYR (0.46) TYRALDH1A3GRIA4CYP2A6SLC6A2
SCHEMBL9950004 0.82 TYR (0.46) TYRALDH1A3GRIA4CYP2A6ALDH1A1
SCHEMBL9949806 0.81 ALDH1A1 (0.36) TYRALDH1A3CYP2A6SLC6A2SLC6A4
SCHEMBL9949675 0.80 TYR (0.43) TYRALDH1A3GRIA4CYP2A6SLC6A2
SCHEMBL16191334 0.78 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1MCOLN3
SCHEMBL16191052 0.76 IDO1 (0.42) ALDH1A1MCOLN3
SCHEMBL9950062 0.73 TYR (0.47) TYRALDH1A3GRIA4CYP2A6SLC6A2
Ethylene SCHEMBL9950389 0.72 TYR (0.36) TYRALDH1A3GRIA4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2476662-B1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL CO (JP) 2018-05-30 EP claimed
EP-2476662-B1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL CO (JP) 2018-05-30 EP disclosed
US-8748078-B2 Cyclic compound, process for preparation thereof, radiation-sensitive composition, and method for formation of resist pattern MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-06-10 US disclosed
EP-2476662-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-18 EP disclosed
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, RER1, REV1 TYR 4864/4885ALDH1A3 2339/4885GRIA4 3422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.